Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

(2015) Adriane D.M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

(2014) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Utility of 18F-FDG PET/CT for Diagnosis and Adjustment of Therapy in Patients with Active Chronic Sarcoidosis

(2012) D. Sobic-Saranovic et al.   JOURNAL OF NUCLEAR MEDICINE

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

(2011) Shengri Liao et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Sarcoidosis

(2011) Michael C. Iannuzzi   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis

(2011) R.L.M. Mostard et al.   RESPIRATORY MEDICINE

Use of Likelihood Ratios Improves Interpretation of Laboratory Testing for Pulmonary Sarcoidosis

(2010) Dieter De Smet et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis

(2009) Ruth G. Keijsers et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE